SEC Info - Genethera Inc - ‘NT 10-K’ for 12/31/18

SEC Info℠

Home

Help

Please Sign In

Genethera Inc – ‘NT 10-K’ for 12/31/18

On: Thursday, 3/28/19, at 9:10pm ET · As of: 3/29/19 · Effective: 3/29/19 · For: 12/31/18 · Accession #: 1654954-19-3579 · File #: 0-27237

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/29/19  Genethera Inc                     NT 10-K    12/31/18    1:34K                                    Blueprint/FA

Notice of a Late Filing of a Form 10-K — Rule 12b-25
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: NT 10-K     Genethera NT 10-K                                   HTML     18K

This is an HTML Document rendered as filed. [ Alternative Formats ]

C: C:

Blueprint

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check One):

☒ Form 10-K

☐ Form 20-F

☐ Form 11-K

☐ Form 10-Q

☐ Form 10-D

☐ Form N-SAR

☐ Form N-CSR

For Period Ended: December 31, 2018

	☐ Transition Report on Form 10-K
	☐ Transition Report on Form 20-F
	☐ Transition Report on Form 11-K
	☐ Transition Report on Form 10-Q
	☐ Transition Report on Form N-SAR

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the items(s) to which the notification relates:

PART I

REGISTRANT INFORMATION

GENETHERA, INC.

Full Name of Registrant:

N/A

Former Name if Applicable

6860 Broadway

Address of Principal Executive Office (Street and Number)

Denver, CO 80221

City, State and Zip Code

PART II

RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

☐

(a)

The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

☒	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K, 10-Q, Form N-SAR, or portion thereof, will be filed on or before the nineteenth calendar day following the prescribed due date; or the subject quarterly of transition report on Form 10-K, or portion thereof be filed on or before the fifth calendar day following prescribed due date; and

☐	(c)	The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III

NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 11-K, 20-F, 10-Q, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period.

The Company is unable to file its Annual Report on Form 10-K for the period ended December 31, 2018 within the prescribed period due to the fact that on 12-6-2018, our investor, FOGT aka Fredric Oeschger, breached the contract agreement with GeneThera. This situation has created a setback preventing the Company from filing the Annual Report with unreasonable effort or expense. The Company management fully expects to be able to file within the additional time allowed by this report.

PART IV

OTHER INFORMATION

(1)	Name and telephone number of person to contact in regard to this notification.

	Tannya L. Irizarry	(303)	506-9367
	(Name)	(Area Code)	(Telephone Number)

(2)

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No

(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐ Yes ☒ No

GENETHERA, INC.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.


Date: March 28, 2019	By: /s/ TANNYA L. IRIZARRY
	Tannya L. Irizarry
	CFO (Interim)

Dates Referenced Herein

This ‘NT 10-K’ Filing	Date	Other Filings

Filed as of / Effective on:	3/29/19	None on these Dates
Filed on:	3/28/19
For Period End:	12/31/18
		List all Filings

↑Top

Filing Submission 0001654954-19-003579 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Genethera Inc – ‘NT 10-K’ for 12/31/18

On: Thursday, 3/28/19, at 9:10pm ET · As of: 3/29/19 · Effective: 3/29/19 · For: 12/31/18 · Accession #: 1654954-19-3579 · File #: 0-27237

Previous ‘NT 10-K’: ‘NT 10-K’ on 3/30/16 for 12/31/15 · Next: ‘NT 10-K’ on 3/30/20 for 12/31/19 · Latest: ‘NT 10-K’ on 3/31/23 for 12/31/22

Notice of a Late Filing of a Form 10-K — Rule 12b-25Filing Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein

Notice of a Late Filing of a Form 10-K — Rule 12b-25
Filing Table of Contents